Core Viewpoint - A lawsuit has been filed against The Bancorp, Inc. and its senior executives for potential violations of federal securities laws, specifically regarding misrepresentation of risks associated with its loan portfolio [1][2]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Delaware, captioned Linden v. The Bancorp, Inc., et al., No. 25-cv-00326, with investors having until May 16, 2025, to seek lead plaintiff status [2]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, representing investors who purchased Bancorp stock [2]. Group 2: Company Background - Bancorp is a financial holding company involved in institutional banking, commercial real estate bridge lending, small business lending, and commercial fleet leasing, with its REBL loans primarily collateralized by apartment buildings [3]. Group 3: Allegations of Misrepresentation - The complaint claims that Bancorp misrepresented the risks of default or loss on its REBL loan portfolio and that its credit loss methodology was inadequate [4]. - It is alleged that Bancorp's internal controls over financial reporting contained at least one material weakness [4]. Group 4: Stock Performance and Impact - Following a report from Culper Research on March 21, 2024, which highlighted the risks associated with Bancorp's REBL loans, the stock price fell over 10%, from $36.04 to $32.12 [5]. - On October 24, 2024, Bancorp reported a net income of $51.5 million, leading to a 14% decline in stock price from $54.96 to $47.01 due to increased credit losses [6]. - On March 4, 2025, Bancorp disclosed issues with its Annual Report for the fiscal year ended December 31, 2024, causing a 4.4% drop in stock price from $53.59 to $51.25 [7].

Group 1 - RH is under investigation for potential violations of federal securities laws, as announced by Bleichmar Fonti & Auld LLP [1] - RH operates primarily in the home furnishings market, offering a variety of products including furniture, lighting, textiles, and outdoor furnishings [2] - Despite claims of accelerated demand, RH was actually facing softening demand and macroeconomic challenges that necessitated delays in new collections [3] Group 2 - On April 2, 2025, RH reported disappointing earnings for FY 2024, citing softening demand and excess inventory valued between $200 million to $300 million [4] - Following the earnings report, RH's stock price plummeted by 40%, dropping from $249.35 to $149.39 per share within a day [4]

NEW YORK, April 28, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2025. Attorney Advertising. Prior results do not guarantee a similar ...

Core Viewpoint - ICU Medical, Inc. is under investigation for potential securities fraud and unlawful business practices following a warning from the FDA regarding unauthorized changes to its infusion pump products [1][2]. Group 1: FDA Warning and Product Issues - On April 22, 2025, ICU disclosed that it received a warning letter from the FDA, which cited unauthorized modifications to two of its infusion pump products [2]. - The FDA's letter described the pumps as "adulterated" and "misbranded," indicating that the changes could significantly affect the functionality of the devices, particularly their delivery profile and alarm functionality [2]. - Concerns were raised about the safety and efficacy of the devices due to these modifications, questioning the adequacy of ICU's regulatory disclosures [2]. Group 2: Stock Market Reaction - Following the FDA warning, ICU's stock price dropped by $6.04 per share, or 4.42%, closing at $130.68 per share on April 22, 2025 [3]. Group 3: Legal Investigation - Pomerantz LLP is investigating claims on behalf of ICU investors regarding potential securities fraud or other unlawful business practices by the company and its officers or directors [1].

Core Viewpoint - Northrop Grumman Corporation is under investigation for potential securities fraud and unlawful business practices following disappointing financial results for Q1 2025, which included significant charges related to its B-21 bomber program [1][2]. Financial Performance - Northrop Grumman reported revenue of $9.47 billion for Q1 2025, reflecting a 7% year-over-year decline and falling short of consensus estimates by $480 million [2]. - The company incurred a pretax charge of $477 million associated with manufacturing updates for the B-21 bomber program, attributed to inflationary factors by the CEO [2]. Stock Market Reaction - Following the announcement of the financial results, Northrop Grumman's stock price dropped by $67.25 per share, or 12.66%, closing at $464.08 per share on April 22, 2025 [2].

Group 1 - Block & Leviton is investigating Landstar System, Inc. for potential securities law violations following a significant drop in share price [1][2] - Shares of Landstar System, Inc. fell over 3% on April 25 after the company announced a delay in filing its 10-Q and postponement of its earnings release to May 13 due to ongoing evaluation of internal accounting controls and financial reporting related to previous supply chain fraud issues [2] - Investors who have lost money in their Landstar System, Inc. investment are encouraged to contact Block & Leviton for potential recovery options [3][5] Group 2 - Block & Leviton is considering filing an action to recover losses on behalf of investors who have been affected by the company's issues [4] - The firm is recognized as a leading securities class action firm, having recovered billions of dollars for defrauded investors [7] - Whistleblowers with non-public information about Landstar System, Inc. may assist in the investigation and could receive rewards of up to 30% of any successful recovery [6]

Core Viewpoint - A class action lawsuit has been filed against BigBear.ai Holdings, Inc. for violations of securities laws, alleging that the company made false and misleading statements regarding its financial disclosures [1][4]. Group 1: Lawsuit Details - The lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased BigBear's securities between March 31, 2022, and March 25, 2025, are encouraged to participate in the class action [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against BigBear - The complaint alleges that BigBear failed to maintain adequate accounting review policies for complex transactions [4]. - The company incorrectly believed that the conversion option in its 2026 Convertible Notes qualified for a derivative scope exception, leading to non-compliance with relevant accounting standards [4]. - As a result of these misstatements, BigBear will need to restate its financial statements, which were deemed false and materially misleading during the class period [4].

LOS ANGELES, April 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Napco Security Technologies, Inc. ("Napco" or "the Company") (NASDAQ: NSSC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2024, and February 3, 2025, inclusive (the ...

Core Viewpoint - Rocket Lab USA, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its operations and business prospects during a specified class period [1][2]. Allegations - The lawsuit claims that Rocket Lab's plans for three barge landing tests were significantly delayed [1]. - A critical potable water issue was not scheduled to be resolved until January 2026, which impacted the launch pad preparation [1]. - There is a substantial risk that Rocket Lab's Neutron rocket will not launch in mid-2025 due to the aforementioned delays [1]. - The only contract for the Neutron rocket was made at a discount with an unreliable partner [1]. - The positive statements made by the defendants about the company's business and prospects were materially misleading and lacked a reasonable basis [1]. Class Action Details - The class period for the lawsuit is from November 12, 2024, to February 25, 2025 [1]. - Shareholders are encouraged to register for the class action by the deadline of April 28, 2025, to potentially be appointed as lead plaintiffs [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2].

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Ready Capital Corporation (NYSE: RC) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Ready Capital, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/ready-capital-corporation. Investors have until May 5, 2025, to ask the Court to be ...